11月12日，麒盛科技盘中上涨2.03%，截至13:31，报21.15元/股，成交1.36亿元，换手率1.84%，总市值 74.66亿元。 责任编辑：小浪快报 资料显示，麒盛科技股份有限公司位于浙江省嘉兴市秀洲区王江泾镇秀水大道1508号，成立日期2005年 10月19日，上市日期2019年10月29日，公司主营业务涉及智能电动床及配套产品研发、设计、生产和销 售。主营业务收入构成为：智能电动床80.92%，配件及其他8.33%，床垫7.38%，其他(补充)3.37%。 麒盛科技所属申万行业为：轻工制造-家居用品-成品家居。所属概念板块包括：家具卫浴、小盘、多胎 概念、增持回购、养老产业等。 截至9月30日，麒盛科技股东户数2.35万，较上期减少24.49%；人均流通股15036股，较上期增加 32.44%。2025年1月-9月，麒盛科技实现营业收入22.24亿元，同比增长0.08%；归母净利润1.47亿元，同 比减少2.74%。 分红方面，麒盛科技A股上市后累计派现7.54亿元。近三年，累计派现3.88亿元。 资金流向方面，主力资金净流出66.84万元，特大单买入207.26万元，占比1.53%，卖出103 ...

资金流向方面，主力资金净流入1310.04万元，特大单买入1259.88万元，占比9.06%，卖出602.69万元， 占比4.34%；大单买入3091.61万元，占比22.24%，卖出2438.77万元，占比17.54%。 11月12日，海澜之家盘中上涨2.06%，截至10:31，报6.44元/股，成交1.39亿元，换手率0.45%，总市值 309.30亿元。 海澜之家今年以来股价跌12.02%，近5个交易日涨3.04%，近20日跌1.53%，近60日跌8.00%。 分红方面，海澜之家A股上市后累计派现214.04亿元。近三年，累计派现65.16亿元。 机构持仓方面，截止2025年9月30日，海澜之家十大流通股东中，香港中央结算有限公司位居第四大流 通股东，持股8325.53万股，相比上期减少295.66万股。华泰柏瑞上证红利ETF（510880）位居第五大流 通股东，持股7772.88万股，相比上期增加432.86万股。南方中证500ETF（510500）位居第六大流通股 东，持股3489.99万股，相比上期减少71.78万股。易方达中证红利ETF（515180）位居第九大流通股 东，持股1945.56万股 ...

11月12日，熊猫乳品盘中下跌2.02%，截至10:19，报28.20元/股，成交1.17亿元，换手率3.58%，总市值 34.97亿元。 资金流向方面，主力资金净流出1105.70万元，特大单买入0.00元，占比0.00%，卖出392.47万元，占比 3.35%；大单买入1941.11万元，占比16.57%，卖出2654.34万元，占比22.66%。 熊猫乳品今年以来股价涨12.31%，近5个交易日涨4.72%，近20日涨2.69%，近60日涨4.37%。 今年以来熊猫乳品已经3次登上龙虎榜，最近一次登上龙虎榜为4月8日。 资料显示，熊猫乳品集团股份有限公司位于浙江省苍南县灵溪镇建兴东路650-668号，成立日期1996年1 月3日，上市日期2020年10月16日，公司主营业务涉及浓缩乳制品的研发、生产和销售以及乳品贸易。 主营业务收入构成为：浓缩乳制品76.14%，乳品贸易11.57%，椰品10.44%，其他1.85%。 熊猫乳品所属申万行业为：食品饮料-饮料乳品-乳品。所属概念板块包括：休闲食品、国产乳业、多胎 概念、小盘、高派息等。 截至9月30日，熊猫乳品股东户数1.70万，较上期减少14.02%； ...

Core Viewpoint - Panda Dairy's stock has shown a positive trend with a year-to-date increase of 14.30%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Panda Dairy reported a revenue of 586 million yuan, representing a year-on-year growth of 3.00% [2]. - The net profit attributable to the parent company for the same period was 71.71 million yuan, which reflects a decrease of 8.17% compared to the previous year [2]. Stock Market Activity - As of November 11, Panda Dairy's stock price was 28.70 yuan per share, with a trading volume of 2.18 billion yuan and a turnover rate of 6.77% [1]. - The stock has appeared on the "龙虎榜" (a list of stocks with significant trading activity) three times this year, with the most recent appearance on April 8 [1]. Shareholder Information - As of September 30, the number of shareholders for Panda Dairy was 17,000, which is a decrease of 14.02% from the previous period [2]. - The average number of circulating shares per shareholder increased by 16.30% to 6,748 shares [2]. Dividend Distribution - Since its A-share listing, Panda Dairy has distributed a total of 205 million yuan in dividends, with 161 million yuan distributed over the past three years [3]. Business Overview - Panda Dairy, established on January 3, 1996, specializes in the research, production, and sales of concentrated dairy products, as well as dairy trading [1]. - The revenue composition of the company includes 76.14% from concentrated dairy products, 11.57% from dairy trading, 10.44% from coconut products, and 1.85% from other sources [1].

Core Insights - The stock price of Bright Dairy increased by 2.11% on November 11, reaching 8.71 CNY per share, with a total market capitalization of 12.007 billion CNY [1] - The company reported a revenue of 18.231 billion CNY for the first nine months of 2025, a year-on-year decrease of 0.99%, and a net profit of 87.2143 million CNY, down 25.05% year-on-year [2] - Bright Dairy has distributed a total of 3.628 billion CNY in dividends since its A-share listing, with 634 million CNY distributed over the past three years [3] Financial Performance - As of September 30, 2025, the number of shareholders decreased by 5.42% to 75,200, while the average number of circulating shares per person increased by 5.74% to 18,340 shares [2] - The stock has shown a year-to-date increase of 3.94%, with a 4.31% rise over the last five trading days [1] Shareholder Composition - The fourth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 11.1106 million shares, a decrease of 2.8573 million shares from the previous period [3] - The sixth largest shareholder is the CSI Shanghai State-Owned Enterprise ETF, holding 7.2473 million shares, down by 0.9324 million shares [3]

Core Viewpoint - The stock of Zhifei Biological has shown fluctuations, with a recent increase of 2.04% but a year-to-date decline of 16.50%, indicating potential volatility in the market [1][2]. Company Overview - Zhifei Biological, established on July 20, 1995, and listed on September 28, 2010, is located in Chongqing and specializes in the research, production, and sales of vaccines and biological products [1]. - The company's revenue composition includes 88.84% from agency products, 10.15% from self-developed products, and 1.00% from other sources [1]. Financial Performance - For the period from January to September 2025, Zhifei Biological reported a revenue of 76.27 billion, a year-on-year decrease of 66.53%, and a net profit attributable to shareholders of -12.06 billion, reflecting a significant decline of 156.10% [2]. - Cumulatively, the company has distributed 73.18 billion in dividends since its A-share listing, with 31.94 billion distributed over the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Zhifei Biological is 131,600, a decrease of 3.17% from the previous period, with an average of 10,750 circulating shares per shareholder, an increase of 3.28% [2]. - The top ten circulating shareholders include significant institutional investors, with notable reductions in holdings for several funds, indicating potential shifts in investor sentiment [3].

Core Insights - The stock price of Pinwo Food increased by 2.04% on November 11, reaching 37.45 CNY per share, with a trading volume of 242 million CNY and a turnover rate of 10.26% [1] - Year-to-date, the stock has risen by 17.39%, with a 10.54% increase over the last five trading days [1] - The company has a market capitalization of 3.745 billion CNY and has appeared on the trading leaderboard twice this year [1] Financial Performance - For the period from January to September 2025, Pinwo Food reported a revenue of 589 million CNY, a year-on-year decrease of 7.69%, while the net profit attributable to shareholders increased by 312.18% to 12.1533 million CNY [2] - The company has distributed a total of 55.9004 million CNY in dividends since its A-share listing, with 9.9004 million CNY distributed over the last three years [3] Shareholder Information - As of September 30, the number of shareholders for Pinwo Food was 13,600, a decrease of 10.59% from the previous period, while the average circulating shares per person increased by 11.85% to 4,739 shares [2] Business Overview - Pinwo Food, established on September 9, 1997, and listed on September 24, 2020, is based in Shanghai and focuses on the development, import, and sales of food products, with a revenue composition of 82.92% from dairy products and 16.72% from beer [1]

Company Overview - Zhejiang Zhenyuan's stock price increased by 2.04% on November 11, reaching 10.02 CNY per share, with a total market capitalization of 3.348 billion CNY [1] - The company has seen a year-to-date stock price increase of 27.64%, with a 5-day increase of 2.98%, a 20-day increase of 5.70%, and a 60-day increase of 5.70% [1] - Zhejiang Zhenyuan has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on July 21, where it recorded a net buy of -9.6038 million CNY [1] Business Performance - For the period from January to September 2025, Zhejiang Zhenyuan reported a revenue of 1.78 billion CNY, a year-on-year decrease of 37.59%, while the net profit attributable to shareholders was 56.0599 million CNY, reflecting a year-on-year increase of 28.67% [2] - The company's main business segments include retail (45.55%), wholesale (28.75%), industrial preparations (14.08%), raw materials (7.94%), health services (2.88%), and others (0.80%) [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 17.24% to 35,800, while the average circulating shares per person decreased by 14.70% to 7,877 shares [2] - The company has distributed a total of 228 million CNY in dividends since its A-share listing, with 60.1422 million CNY distributed in the last three years [3] Industry Context - Zhejiang Zhenyuan operates within the pharmaceutical and biological sector, specifically in pharmaceutical commerce and distribution, and is associated with concepts such as cold chain logistics, medical devices, and digital economy [2]

Core Viewpoint - The stock of Hailan Home has shown fluctuations, with a recent increase of 2.09% on November 10, 2023, despite a year-to-date decline of 13.25% [1] Financial Performance - For the period from January to September 2025, Hailan Home achieved a revenue of 15.599 billion yuan, representing a year-on-year growth of 2.23%, while the net profit attributable to shareholders decreased by 2.37% to 1.862 billion yuan [2] - Cumulative cash dividends since the A-share listing amount to 21.404 billion yuan, with 6.516 billion yuan distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 17.10% to 62,700, while the average circulating shares per person decreased by 14.60% to 76,659 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 83.2553 million shares, a decrease of 2.9566 million shares from the previous period [3] Market Activity - The stock's trading volume on November 10, 2023, reached 258 million yuan, with a turnover rate of 0.85% and a total market capitalization of 30.498 billion yuan [1] - The stock has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on January 2 [1]

Core Viewpoint - The stock of Jia Bi You has shown a mixed performance in recent trading sessions, with a year-to-date increase of 29% but a decline over the past 20 and 60 days, indicating volatility in investor sentiment [1][2]. Group 1: Stock Performance - On November 10, Jia Bi You's stock rose by 2.02%, reaching a price of 24.29 yuan per share, with a trading volume of 34.99 million yuan and a turnover rate of 0.87% [1]. - Year-to-date, Jia Bi You's stock has increased by 29.00%, while it has seen a decline of 7.04% over the past 20 days and 12.94% over the past 60 days [1]. - The company has appeared on the "龙虎榜" (a stock trading list) once this year, with the most recent appearance on March 14, where it recorded a net buy of 18.50 million yuan [1]. Group 2: Company Overview - Jia Bi You Biotechnology (Wuhan) Co., Ltd. was established on September 22, 2004, and went public on December 19, 2019. The company specializes in the research, production, and sales of polyunsaturated fatty acids such as ARA and DHA, as well as natural β-carotene [2]. - The main revenue sources for Jia Bi You are ARA products (76.16%), DHA products (21.24%), and other supplements (2.60%) [2]. - The company operates within the basic chemical industry, specifically in food and feed additives, and is associated with concepts such as pet economy and synthetic biology [2]. Group 3: Financial Performance - For the period from January to September 2025, Jia Bi You achieved a revenue of 428 million yuan, reflecting a year-on-year growth of 10.56%, while the net profit attributable to the parent company was 129 million yuan, marking a significant increase of 54.18% [2]. - Since its A-share listing, Jia Bi You has distributed a total of 243 million yuan in dividends, with 103 million yuan distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders increased to 8,362, with an average of 20,127 circulating shares per person, a slight decrease of 1.00% from the previous period [2].